) and generic biological pathways (Table S2) (Table 4 ) and generic biological pathways (Table S3 ) based on shared gene membership. The thickness of the edges corresponds to the proportion of overlap from the smaller term to the larger (overlap coefficient). Intensity of shading indicates p-value (darker colours have lower p-values), node size indicates size of gene content, node shape indicates origin of data (modules or pathways). For clarity, biological pathways with similar gene content are grouped together, as described in Supplementary Table S19 , and the shading reflects the most significant pathway in the group. Nodes are arranged such that the distance between them reflects similarity in gene content. Diagram rendered in Cytoscape. Table S1 . Differential expression analysis in HD (premanifest and manifest combined) versus controls for the combined Track-HD and Leiden cohorts. p (diffexp) -p value for differential expression between HD and controls; q (diffexp) -q value shows correction for multiple testing in the combined dataset; Log2(FC) -log2 of the ratio of the mean counts in HD and controls. Table S6 . Number of pathways nominally significantly enriched (uncorrected p<0.05) in both the combined Track-HD/Leiden blood dataset and the unstimulated myeloid data of Miller, et al. 1 . The p-value measures whether there is an excess of significantly enriched pathways in the blood dataset conditional on the pathway being enriched (p < 0.05) in the myeloid dataset. The set of pathways was collated from publiclyavailable databases including GO and KEGG. FC_BA4 -BA4 region of the frontal cortex; FC_BA9 -BA9 region of the frontal cortex; CB -cerebellum; TCTX -temporal cortex. Figure S1 . Figure S2 .
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cortex; Blood/brain p the p value for module enrichment in HD relative to controls in the combined Track-HD and Leiden blood dataset (combined) or the prefrontal cortex dataset (Labadorf
